ES
LABORATORIOS
OJER PHARMA
INNOVATION AS A PHILOSOPHY
COLLABORATIVE
NETWORKS
ALWAYS SEARCHING FOR EXCELLENCE
COLLABORATIVE
NETWORKS
BUILDING STRONG RELATIONSHIPS WITH OUR PARTNERS AND COLLABORATORS
COLLABORATIVE
NETWORKS
BELIEVING IN PEOPLE AS A FUNDAMENTAL PART FOR PROGRESS
COLLABORATIVE
NETWORKS
RESEARCH AND DEVELOPMENT TO PROVIDE BETTER SOLUTIONS

Who we are

Laboratorios Ojer Pharma is a New Technology-Based Company (NEBTs) that focuses all its efforts on the development of innovative pharmaceutical products to provide real solutions in dermatology. Our expertise is the research and development of innovative pharmaceutical forms to improve the properties of the conventional formulations and ameliorate the current therapeutic options.

What we offer?

Develop new products and delivery technologies
through collaborative projects.

What we look for?

Strategic partners interested in expanding and completing their dermatological product portfolio with innovative and attractive products.

ABOUT US

NEWS

Gobierno de España. Ministerio de Economía y Competitividad

FIRST EUROPEAN AUTHORIZATION FOR THE COMMERCIALIZATION OF THEIR INNOVATIVE ANTIBIOTIC IMPETINE® GEL

Pharmaceutical companies Reig Jofre and Ojer Pharma have recently received market authorization from the Portuguese Medicines Agency (Infarmed) for Impetine® Gel, an innovative mupirocin antibiotic bioadhesive gel used for the treatment of primary dermatological infections such as impetigo, folliculitis and furunculosis, and secondary infections such as overinfected dermatoses of the skin.

Funding granted to the project Proderma

FUNDING GRANTED
TO THE PROJECT INNOLFACT

By RESOLUTION 101E / 2020, of September 10, which determines the 2019 call of grants for strategic R&D projects, the granting of financing for the development of the INNOLFACT project: Implementation of precision olfactory medicine and development of immunomodulatory nasal therapies in aging and neurodegeneration.

FUNDING GRANTED TO THE PROJECT TRANSPARENT BIOADHESIVE GELS (TBGs): INNOVATIVE VEHICULIZATION TECHNOLOGY FOR TOPICAL MEDICAMENTS

The State Secretariat for Research, Development and Innovation has published the Resolution of the granting of funding for the development of the project corresponding to the call Horizonte Pyme of the State Program of Business Leadership in the framework of the State Plan for Scientific and Technical Research and Innovation 2013-2016.

Technology

MEDICINES FOR
SKIN CARE

Ojer Pharma has developed an innovative platform of bioadhesive gels with important competitive advantages.
Our patented technology has been applied to:

Patents

REQUESTED IN PROCESS GRANTED
AMERICA 03 02 03
EUROPE 00 00 09
AFRICA 00 00 02
ASIA 05 03 03
OCEANIA 01 01 02

KEY ACTIVITIES

We carry out all the R&D process from
Business intelligence to Open innovation

01 BUSINESS
INTELLIGENCE
02 PHARMACEUTICAL
DEVELOPMENT
03 NON-CLINICAL
DEVELOPMENT
04 CLINICAL
DEVELOPMENT
05 REGULATORY
STRATEGY
06 OPEN
INNOVATION
COLLABORATIVE
NETWORKS UNIVERSIDAD
DE NAVARRA

Interschool departments teach in the Faculty of Pharmacy Science and Medicine and collaborate with the Center for Applied Medical Research (CIMA), the Center for Applied Medical Pharmacobiology (CIFA) and the Clínica Universidad de Navarra (CUN).

SEE MORE
COLLABORATIVE
NETWORKS UNIVERSIDAD
DE BARCELONA

The UB, through the Pharmacy Faculty, and managed by the Fundación Bosch I Gimpera (FBIG), set up the Service of Development of Medicines (SDM) to make the necessary collaboration between the university and the pharmaceutical industry possible.

SEE MORE